z-logo
open-access-imgOpen Access
Long-Acting Lanreotide Induces Clinical and Biochemical Remission of Acromegaly Caused by Disseminated Growth Hormone-Releasing Hormone-Secreting Carcinoid
Author(s) -
M. R. Drange
Publication year - 1998
Publication title -
the journal of clinical endocrinology and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.206
H-Index - 353
eISSN - 1945-7197
pISSN - 0021-972X
DOI - 10.1210/jc.83.9.3104
Subject(s) - lanreotide , acromegaly , medicine , somatostatin , endocrinology , octreotide , somatotropic cell , hormone , growth hormone–releasing hormone , pegvisomant , pituitary gland , growth hormone

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom